ProfileGDS4132 / 36030_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 65% 63% 68% 66% 60% 66% 64% 69% 75% 64% 63% 73% 71% 71% 67% 68% 75% 77% 76% 61% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101186.10565
GSM201543Muscle PCOS pioglitazone 121169.86963
GSM201544Muscle PCOS pioglitazone 161202.10568
GSM201545Muscle PCOS pioglitazone 201204.94966
GSM201829Muscle PCOS pioglitazone 231177.89860
GSM201830Muscle PCOS pioglitazon 251199.40266
GSM201831Muscle PCOS pioglitazone 271187.87564
GSM201832Muscle PCOS pioglitazone 31195.17269
GSM201833Muscle PCOS pioglitazone 41231.85675
GSM201834Muscle PCOS pioglitazone 81183.95164
GSM201835Muscle PCOS after pioglitazone 102167.52463
GSM201836Muscle PCOS after pioglitazone 122218.89173
GSM201837Muscle PCOS after pioglitazone 162199.11171
GSM201838Muscle PCOS after pioglitazone 202209.27971
GSM201839Muscle PCOS after pioglitazone 232196.68467
GSM201840Muscle PCOS after pioglitazone 252203.24768
GSM201841Muscle PCOS after pioglitazone 272227.04275
GSM201842Muscle PCOS after pioglitazone 32229.06177
GSM201843Muscle PCOS after pioglitazone 42239.88876
GSM201844Muscle PCOS after pioglitazone 82171.00661